Intravenous tissue plasminogen activator thromblysis 2.
Transesophageal echocardiogram  History of Present Illness: Patient is a 42 year old male with past medical history of deep vein thrombosis, pulmonary embolus, hypercholesterolemia, and asthma who was admitted to [**Hospital1 69**] on [**2104-11-9**] for evaluation and management of acute stroke.
While doing exercises including sit ups and push ups, he experienced sudden onset of left hand tingling and dysequilibrium.
He was enrolled in the DEFUSE trial and administered IV tPA (0.9 mg/kg) at 8:40 pm.
This occurred in the setting of leg injury and travel.
He was treated with coumadin for 6 months.
Fair performance on testing of visuospatial skills and visual memory.
Pertinent Results: [**2104-11-9**] 07:30PM   WBC-8.6 RBC-4.78 HGB-15.2 HCT-42.6 MCV-89 MCH-31.8 MCHC-35.7* RDW-12.5 [**2104-11-9**] 07:30PM   PLT COUNT-154 [**2104-11-9**] 07:30PM   PT-12.0 PTT-21.7* INR(PT)-0.9 [**2104-11-9**] 07:30PM   GLUCOSE-102 UREA N-15 CREAT-1.0 SODIUM-139 POTASSIUM-4.6 CHLORIDE-104 TOTAL CO2-28 ANION GAP-12 [**2104-11-10**] 06:16AM BLOOD Triglyc-64 HDL-53 CHOL/HD-2.3 LDLcalc-56 [**2104-11-13**] 05:15PM BLOOD ESR-7 [**2104-11-13**] 05:15PM BLOOD FacVIII-125 [**2104-11-13**] 05:15PM BLOOD Lupus-NEG AT III-PND Prot C-PND [**2104-11-10**] 06:16AM BLOOD %HbA1c-5.4 [**2104-11-13**] 05:15PM BLOOD Homocys-8.3 [**2104-11-13**] 05:15PM BLOOD [**Doctor First Name **]-POSITIVE Titer-1:40 [**2104-11-13**] 05:15PM BLOOD CRP-0.32 [**2104-11-13**] 05:15PM BLOOD ACTIVATED PROTEIN C -PND [**2104-11-13**] 05:15PM BLOOD PROTHROMBIN MUTATION ANALYSIS-PND [**2104-11-13**] 05:15PM BLOOD FACTOR V LEIDEN-PND [**2104-11-13**] 05:15PM BLOOD PROTEIN S,FUNCTIONAL-PND ----- MRI/MRA head pre-tPA [**11-9**]: There is a large region of slowed diffusion in the right posterior cerebral artery territory consistent with an acute infarction.
Otherwise, flow signal is observed in the left posterior cerebral artery, both vertebral arteries and the basilar artery, as well as in the internal carotid arteries, anterior and middle cerebral arterial branches.
He was enrolled in the DEFUSE trial and administered IV tPA (0.9mg/kg) at 8:40pm.
The patient was admitted to the neurology service and treated initially with aspirin 325mg.
The patient was started on an antiplatelet regimen of baby aspirin plus aggrenox (aspirin/dipyridamole).
Physical therapy and occupational therapy consults were obtained.
Upon discharge, patient was neurologically stable with residual left field cut, left-sided paresthesias and left-sided ataxia.
ASA 81 mg po qd 2.
Lipitor 3.
Atorvastatin Calcium 10 mg Tablet Sig: One (1) Tablet PO QD (once a day).
Aspirin 81 mg Tablet, Chewable Sig: One (1) Tablet, Chewable PO QD (once a day).
Dipyridamole-Aspirin 200-25 mg Capsule, Multiphasic Release Sig: One (1) Cap PO QD (once a day): Increase to one capsule [**Hospital1 **] on Friday [**11-14**].
Outpatient Occupational Therapy To increase functional status of left upper extremity, especially coordination.
Discharge Instructions: Please call your primary care physician or visit local emergency room if you experience any headaches, confusion, changes in your ability to speak or understand speech, loss of function in any limb, numbness or tingling over your limbs or face, weakness, visual changes.
Please take all medications as prescribed.
The following appointment has already been scheduled--DRIVEWISE: [**Hospital Ward Name **] BUILDING BEHAVIORAL NEUROLOGY, Phone:[**Telephone/Fax (1) 1690**], Date/Time: [**2104-12-9**] 11:00.
